Finnish study links 10 health conditions to early-onset Alzheimer's

Researchers in Finland identified ten medical conditions that appear with greater frequency in the five years before a diagnosis of early-onset Alzheimer's disease, according to a new study published in the journal Alzheimer's & Dementia. The findings suggest these health issues may serve as potential indicators for earlier detection of the condition in people under 65.

The observational study analyzed medical records from 407 individuals diagnosed with early-onset Alzheimer's disease and 4,035 control participants of similar age and sex who did not have the diagnosis. The average age at diagnosis for the Alzheimer's group was 60. Researchers examined data spanning the 15 years prior to diagnosis, noting that differences in specific medical conditions were most pronounced in the final five years leading up to the clinical diagnosis.

Conditions found to be significantly more prevalent among those eventually diagnosed with early-onset Alzheimer's included depression, vertigo, and headaches. The study also observed a substantial increase in healthcare visits among patients immediately before and during the period of diagnosis, which may reflect emerging symptoms as the disease progresses.

Suvi-Johanna Krüger, M.D., Ph.D., a study co-author and clinical lecturer at the University of Oulu, noted that neuropathological changes associated with Alzheimer's disease typically begin at least 15 to 20 years before clinical cognitive symptoms appear. Most previous research has focused on late-onset Alzheimer's disease, leaving considerably less known about the early-onset form. Krüger emphasized that the study establishes associations rather than causation.

Krüger stated in a press release that the data does not clarify if these conditions are the cause of early-onset Alzheimer's or merely results of the underlying disease process. Some of these conditions may represent risk factors, while others might reflect early symptoms or changes occurring during the prodromal phase of the disease. The researchers acknowledged that genetics, lifestyle, and socioeconomic factors could also have played a role in the patients' outcomes.

The study has limitations, including the inability to independently verify all medical diagnoses or assess the severity of the patients' disease. Furthermore, because the research was conducted in Finland, the findings may not apply to populations outside the country. Larger studies examining disease biomarkers, genetics, and clinical assessments are needed to determine if there is a causal relationship between these medical conditions and Alzheimer's incidence.

Despite these limitations, the research highlights the importance of early diagnosis. Krüger advised that individuals experiencing persistent medical symptoms, including memory or cognition issues, should consult a healthcare provider. Early diagnosis allows patients and their families more time to plan for the future and access available treatment options and support services.